Autoimmunity

About Conference

“AUTOIMMUNITY 2023” Conference is a global platform to discuss and learn about Immunology, Autoimmune Disease, Infection and Autoimmunity, Autoimmunity in Women, Autoimmune & Inflammatory Diseases, Thyroid Autoimmunity, Therapy of Autoimmune Liver Disease, Immunotherapy, Molecular Immunology, Cancer Immunology, Clinical Immunology, Translational Immunology, Types of Immunology, Immune Diseases, Peptides and Autoimmune Diseases, Prediction, Monitoring and Prevention.

“17th International Congress on Autoimmunity” mainly focuses on the gathering and concentrates on the trending advances and development in every aspect of Autoimmunity research which takes an opportunity in meeting, organizing and see the new logical advancements of the specialists and researchers. We foresee a great scientific faculty from Thailand and in addition from different nations with some highly interesting scientific researchers to delegate the occasion. We unconditionally invite all the prominent, Professors, Students and delegates to participate in this upcoming Autoimmunity event to witness a valuable scientific occasion and to participate in Autoimmunity Workshop, Autoimmunity Symposium & contribute to the future innovations in the field of Immunology.

Autoimmunity 2023 is the main gathering where you can find out about immune system illnesses from an assortment of points of view, both research-based and clinical. We will examine the freshest remedial systems and demonstrative instruments just as the most modern research on hereditary, etiology, symptomatic, clinical angles and novel treatments of immune system illnesses. Autoimmunity Conferences furnishes an opportunity to team up with industry peers and find information and assets that can be utilized to accomplish your own and hierarchical objectives

Why to attend?

Autoimmunity is a stage for, (Doctors, investigate researchers, understudies, mechanical and pharma experts) to uncover their exploration work, to Share their insight in resistance maladies. It is a chance to associate with individuals over the globe concentrated on finding out about Immunology. Incredibly famous speakers, the latest treatments and the most recent updates in Autoimmunity for Immunology are signs of this gathering.

Target Audience:

· Allergists

· Immunologists

· Microbiologists

· Pediatricians

· Physicians

· Academicians

· Health Care experts

· Young Research Scholars

· Students

· Society and Organizational Members

Session Tracks

Track 1: Autoimmune Diseases

Autoimmunity is the process of Immune Responses of an organism against its own tissues and cells. Any disease that results from such an unusual immune response is termed an autoimmune disease. Prominent examples include Diabetes Mellitus type 1, Systemic lupus Erythematous, Celiac disease, Sarcoidosis. Autoimmune diseases are very often treated with steroids.

Track 2: Infection and Autoimmunity

Virus infection may be a primary issue that has been concerned within the initiation of disease. Infection triggers a strong and frequently well-coordinated reaction that's important for infective agent clearance. However, in some instances, immune regulative mechanisms might falter, culminating within the breakdown of self-tolerance, leading to immune-mediated attack directed against each infective agent and self-antigens.

Track 3:  Autoimmunity in Women

The majority of people living with autoimmune complaints are women, frequently those who are of childbearing age. Autoimmune diseases, majority of these diseases are more common in women than in men a predictable 75% because this higher prevalence is partly attributable to the X chromosome, which has many genes relating to the immune system. Autoimmune diseases attack in women three times more than men. Some Autoimmune diseases have an even complex incidence in women.

Track 4: Autoimmune & Inflammatory Diseases

The immune system has the capacity to mount an immune response to virtually all molecules and/or cells. Although the capacity to respond to self-antigen is present in all of us, in most instances such responses result in tolerance, indicating that mechanisms must exist to prevent or subdue autoimmune responses. Moreover, auto-reactive T and B cells, as well as auto-antibodies, are found in people who do not have autoimmune diseases, demonstrating that immunological auto-reactivity alone is not sufficient for the development of the disease. The mechanisms currently thought to prevent/dampen autoimmune responses include inactivation or deletion of auto reactive B and T cells, active suppression by cells or cytokines, idiotype or anti-idiotype interactions, and the immunosuppressive adrenal hormones, the glucocorticoids.

Track 5: Thyroid Autoimmunity

Autoimmune thyroiditis is a chronic disease in which the body interprets the thyroid glands and its hormone products T3, T4 and TSH as threats, therefore producing special antibodies that target the thyroid’s cells, thereby destroying it. The symptoms may vary depending on the thyroid function, i.e. hyperthyroidism or hypothyroidism. Hyperthyroidism will cause sweating, speedy pulse rate, anxiety, tremors, fatigue, problem sleeping, unexpected weight loss, and sticking eyes. Hypothyroidism will cause weight gain, fatigue, dry skin, hair loss, intolerance to cold, and constipation. Autoimmune thyroiditis has a higher prevalence in societies that have a higher intake of iodine in their diet

Track 6:  Therapy of Autoimmune Liver Disease

Autoimmune hepatitis is a disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The disease is chronic, meaning it lasts many years. If untreated, it can lead to cirrhosis and liver failure. There are two forms of this disease. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response.

Track 7: Immunotherapy

Immunotherapy is the treatment of disease by activating or suppressing the immune system. The use of immune system components or antigens to treat a disease or disorder is known as immunotherapy.  Immunotherapy is most commonly used to treat allergies, autoimmune disorders such as Crohn’s disease and rheumatoid arthritis, and certain cancers. Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

Track 8: Molecular Immunology

Molecular immunology is a branch of immunology that concentrates to diagnose and analyze immune system and its processes at a molecular level. The immune system is the system that protects the living body from foreign entities, such as bacteria or other infectious agents in the body. The immune system has been divided into a more primitive innate immune system and, in vertebrates, an acquired or adaptive immune system. Molecular immunology deals with immune responses at cellular and molecular level. Molecular immunology has been evolved for better understanding of the sub-cellular immune responses for prevention and treatment of immune related disorders and immune deficient diseases.

Track 9: Cancer Immunology

Cancer immunology is division of biology which deals with understanding the role of the immune system in the development of cancer and string. The most well notable application in cancer immunology is cancer immunotherapy which taps the immune system as a treatment for cancer.

Track 10: Clinical Immunology

Immunology is the study of the immune system. The immune system is how all animals, including humans, protect themselves against diseases. The study of diseases caused by disorders of the immune system is clinical immunology. The disorders of the immune system fall into two broad categories:

· Immunodeficiency, in this immune system fails to provide an adequate response.

· Autoimmunity, in this immune system attacks its own host's body.

Track 11: Translational Immunology

Translational immunology is the process by which researchers use immunological discoveries to develop practical solutions for human problems. Examples include the development of vaccines against infectious diseases or the engineering of new types of drugs to treat inflammatory disorders.

Track 12: Types Of Immunology

Immunology charts, measures, and contextualizes the physiological functioning of the immune system in states of both health and diseases malfunctions of the immune system in immunological disorders such as autoimmune diseases hypersensitivities immune deficiency, and transplant rejection the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. The study of the molecular and cellular elements that comprise the system as well as their operate and interaction is that the central science of medical specialty. Medical specialty has applications in varied disciplines of drugs notably within the fields of organ transplantation, oncology, medical specialty, virology, medical specialty, parasitology, psychiatry, and medical specialty. The body substance (antibody) response is outlined because the interaction between antibodies and antigens.

Track 13: Immune Diseases

The immune system has developed a variety of approaches to controlling viral and bacterial infection, which range from direct killing of pathogen to elaborating cytokines that inhibit replication.  Pathogens have countered by developing a variety of immune evasion mechanisms that inhibit cytokine function and prevent immune recognition of infected cells.  The human immune system typically produces both T cells and B cells that are capable of being reactive with self-antigens, but these self-reactive cells are usually either killed prior to becoming active within the immune system, placed into a state of, or removed from their role within the immune system by regulatory cells.

Track 14: Peptides and Autoimmune Diseases

Several self-molecules are known as target antigens in reaction diseases. Since lack or loss of tolerance to those molecules is one among the key events promoting pathology, researchers area unit exploring the chance that the administration of antigens or peptides might stimulate tolerogenic mechanisms and delay or forestall the complete phenotypical expression of reaction diseases.

Track 15: Prediction, Monitoring and Prevention

Forecast the end result of medical aid in clinical trials, or aid in developing improved treatments or preventative measures. All of those applications are applied to the response diseases. As a case in purpose, we've got through the years used biomarkers to predict status and therefore the longer-range outcome of thyroid pathology using, variety of various approaches

Market Analysis

One of the elements of the insusceptible framework is to ensure the body by reacting to attacking microorganisms, for example, infections or microscopic organisms, by creating antibodies or sharpened lymphocytes (kinds of white platelets). Under typical conditions, a safe reaction can't be activated against the cells of one's own body. Now and again, be that as it may, insusceptible cells commit an error and assault the very cells that they are intended to ensure. This can prompt an assortment of immune system infections. They envelop a general classification of related ailments in which the individual's safe framework assaults his or her very own tissue. 

Significance and Scope: 

17th International Conference on Autoimmunity offers a chief gathering for discourses and discussions, in this entrancing interdisciplinary field of Immunology, Molecular science, Molecular medication, Microbiology which are concentrating and merging their particular disclosures and advances Examine developing issues in Immunology, Molecular Biology Examine and apply ongoing examination discoveries identified with Molecular Immunology 

Market an incentive on Autoimmunity Research: 

The Global incomes for Autoimmunity 2023 market is assessed at $62.57 billion of every 2020 and is relied upon to reach $160.24 billion by 2023 developing at a CAGR of 18.3% from 2020 to 2027. 

The Australia Autoimmunity 2023 Market was worth $28.52 Billion of every 2020 and assessed to reach $50.71 Billion before the finish of 2027 with a developing capability of 12.20 %. 

The Europe Autoimmunity 2023 Market was assessed to reach $23.41 Billion before the finish of 2027 with a developing capability of 12.45 %. 

Asia Pacific Autoimmunity 2023 market is expecting a sound development of CAGR of 15.5% amid the determined period 2020-2027. 

The LAMEA (Latin America, Middle East and Africa) Autoimmunity 2023 Market is expecting a sound development of 17.9% CAGR amid the gauge time frame (2017 – 2023).

Growth Rate of Immunology:

Accuracy Medicine Market: 

The prescription market represented $43.59 billion out of 2016 and is evaluated to reach $141.70 billion by 2026. The market is required to develop at a compound yearly development rate (CAGR) of 11.23% between the years 2017 and 2026. 

The Europe accuracy drug showcase was esteemed at around USD 33,200.0 million in the year 2014 and it is required to reach roughly USD 35,500.0 million by 2024. The Europe accuracy prescriptions advertise is relied upon to show a CAGR of more than13% somewhere in the range of 2017 and 2025. 

Asia-Pacific Precision Medicine Market is evaluated to develop at a CAGR of 12.4% amid the anticipated period. Japan represented the biggest piece of the pie in 2015, with a market estimation of USD 1.30 billion and is anticipated to develop at a CAGR of 11.4% amid the figure time frame. 

The Latin America Precision Medicine showcase has been evaluated at USD 4.05 Billion of every 2016 and is anticipated to reach USD 7.23 Billion by 2021, at a CAGR of 12.3% amid the conjecture time frame from 2016 to 2025.

Major Universities on Immunology Research:

University of Melbourne

Monash University

University of New South Wales

University of Queensland Australia

University of Sydney

University of Western Australia

Australian National University

Pharma companies:

Roche Products PTY Ltd

LEO Pharma

Luina Bio

Sanofi Consumer Healthcare

Tripak Pharmaceuticals

Invion Limited

Sigma Co.

Mylan

BJP Laboratories

Perrigo Australia

Australia Natural Pharmaceutical Group Pty Ltd

Past Conference

The 35^th International Conference on Vaccines and Immunization (Vaccines & Immunization 2019) hosted by Conference Series LLC Ltd took place at Brisbane, Australia during November 12-13, 2019. It was organized by Conference Series LLC Ltd and generous response was received from the Editorial Board Members of Conference Series LLC Ltd Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2019 from Conference Series LLC Ltd. The two day program witnessed thought provoking Keynote and Plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme, “Scrutinizing Recent Advancements in Vaccines & Immunization".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

• Vaccines         
• Vaccine Preventable Diseases 
• Immunization 
• Veterinary Vaccines   
• Vaccines against Infectious Diseases  
• Plant-Based Vaccines 
• Types of Immunology
• Immunoresearch & Immunotechnology         
• Autoimmune & Inflammatory Diseases          
• Immune Diseases        
• Making a Session Plan
• Giving Vaccinations    ‎
• HIV Vaccines 
• Vaccines Production and Development          
• Onco Immunology      
• Zika Virus Vaccines   
• Protein Based Vaccines          
• Tuberculosis Vaccines
• Toxoid Vaccines

The highlights of the meeting were the keynote lectures from

• Ivana Haluskova Balt, French Society of Immunology, France
• Rod Cook, James Cook University, Australia
• Igor Klepikov, Tel-Aviv Medical Center, Russia
• Dina Arisonaningtyas, Public Health and Nursing Universitas Gadjah Mada, Indonesia

Vaccines & Immunization 2019 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We would specially thank the Moderators Rod Cook, James Cook University, Australia for him contribution for the conference. We would also like to thank Igor Klepikov, Tel-Aviv Medical Center, Russia and Dina Arisonaningtyas, Public Health and Nursing Universitas Gadjah Mada, Indonesia for Speakers at our conference sessions.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines & Immunization 2019 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC would like to announce the commencement of “14^th International Congress on Autoimmunity during June 22-23, 2020 at Brisbane, Australia".

For more Details about the Conference please visit: https://autoimmunity.global-summit.com/